Determinants of minimal elevation in high-sensitivity cardiac troponin T in the general population

Jonathan Rubin1, Kunihiro Matsushita2, Mariana Lazo2

  • 1Department of Medicine, Columbia University Medical Center, New York, NY, USA; Department of Medicine, Johns Hopkins Hospital, Baltimore, MD, USA.

Clinical Biochemistry
|March 16, 2016
PubMed

Insights

Cardiovascular risk factors like hypertension and diabetes are linked to detectable cardiac troponin-T (hs-cTnT) in adults without heart disease. Even individuals with ideal cardiovascular health showed detectable hs-cTnT levels.

Area of Science:

  • Cardiology
  • Biomarkers
  • Public Health

Background:

  • Cardiac troponin-T (hs-cTnT) is a biomarker for cardiac injury.
  • Detecting hs-cTnT in individuals without cardiovascular disease (CVD) is not well understood.
  • Understanding associations between CVD risk factors and hs-cTnT is crucial for early detection.

Purpose of the Study:

  • To investigate the relationship between cardiovascular risk factors and detectable hs-cTnT.
  • To analyze these associations in a population free of diagnosed CVD.
  • To utilize a highly sensitive assay (hs-cTnT) for precise detection.

Main Methods:

  • Cross-sectional study of 9593 participants from the Atherosclerosis Risk in Communities (ARIC) Study.
  • Multivariable logistic regression used to assess associations.
  • Defined detectable hs-cTnT as ≥3.0 to 13.9 ng/L and elevated as ≥14.0 ng/L.

Main Results:

  • hs-cTnT was detectable in 59% and elevated in 7% of participants.
  • Detectable hs-cTnT was more common in males, Black individuals, and those with diabetes or hypertension.
  • Older age, higher BMI, and lower kidney function were also associated with detectable hs-cTnT.

Conclusions:

  • Detectable hs-cTnT is prevalent in adults without CVD, including those with ideal cardiovascular health.
  • Traditional CVD risk factors, notably sex, age, race, hypertension, and diabetes, are robustly associated with detectable hs-cTnT.
  • These findings highlight the importance of hs-cTnT as a potential indicator even in asymptomatic individuals.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.1K
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
411
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
733
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.5K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
661
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
779